US Stock MarketDetailed Quotes

EWTX Edgewise Therapeutics

Watchlist
  • 31.980
  • +0.030+0.09%
Close Nov 21 16:00 ET
  • 31.930
  • -0.050-0.16%
Post 20:01 ET
3.03BMarket Cap-21320P/E (TTM)

Edgewise Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
37.28%40.43M
50.39%38.11M
35.20%34.75M
59.59%114.36M
53.37%33.86M
61.27%29.45M
53.65%25.34M
73.37%25.7M
65.82%71.66M
72.20%22.08M
Selling and administrative expenses
44.90%8.21M
28.49%7.43M
21.12%7.06M
33.05%23.45M
13.01%6.18M
29.72%5.67M
41.35%5.78M
57.43%5.83M
59.86%17.63M
46.41%5.47M
-General and administrative expense
44.90%8.21M
28.49%7.43M
21.12%7.06M
33.05%23.45M
13.01%6.18M
29.72%5.67M
41.35%5.78M
57.43%5.83M
59.86%17.63M
46.41%5.47M
Research and development costs
35.47%32.22M
56.86%30.68M
39.33%27.69M
68.24%90.91M
66.65%27.68M
71.20%23.79M
57.71%19.56M
78.68%19.88M
67.86%54.03M
82.79%16.61M
Operating profit
-37.28%-40.43M
-50.39%-38.11M
-35.20%-34.75M
-59.59%-114.36M
-53.37%-33.86M
-61.27%-29.45M
-53.65%-25.34M
-73.37%-25.7M
-65.82%-71.66M
-72.20%-22.08M
Net non-operating interest income expense
68.57%6.3M
70.80%6.61M
117.31%6.23M
253.26%14.19M
39.60%3.72M
389.40%3.74M
812.74%3.87M
1,626.51%2.87M
899.50%4.02M
2,014.29%2.66M
Non-operating interest income
68.57%6.3M
70.80%6.61M
117.31%6.23M
253.26%14.19M
39.60%3.72M
389.40%3.74M
812.74%3.87M
1,626.51%2.87M
899.50%4.02M
2,014.29%2.66M
Other net income (expense)
Income before tax
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
Income tax
Net income
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
Net income continuous Operations
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
Minority interest income
Net income attributable to the parent company
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-32.73%-34.13M
-46.71%-31.5M
-24.90%-28.53M
-48.08%-100.16M
-55.26%-30.14M
-46.95%-25.71M
-33.62%-21.47M
-55.78%-22.84M
-57.99%-67.64M
-52.92%-19.42M
Basic earnings per share
12.20%-0.36
0.94%-0.3368
8.33%-0.33
-24.60%-1.57
-56.67%-0.47
-20.59%-0.41
-6.25%-0.34
-20.00%-0.36
-10.53%-1.26
-25.00%-0.3
Diluted earnings per share
12.20%-0.36
0.94%-0.3368
8.33%-0.33
-24.60%-1.57
-56.67%-0.47
-20.59%-0.41
-6.25%-0.34
-20.00%-0.36
-10.53%-1.26
-25.00%-0.3
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 37.28%40.43M50.39%38.11M35.20%34.75M59.59%114.36M53.37%33.86M61.27%29.45M53.65%25.34M73.37%25.7M65.82%71.66M72.20%22.08M
Selling and administrative expenses 44.90%8.21M28.49%7.43M21.12%7.06M33.05%23.45M13.01%6.18M29.72%5.67M41.35%5.78M57.43%5.83M59.86%17.63M46.41%5.47M
-General and administrative expense 44.90%8.21M28.49%7.43M21.12%7.06M33.05%23.45M13.01%6.18M29.72%5.67M41.35%5.78M57.43%5.83M59.86%17.63M46.41%5.47M
Research and development costs 35.47%32.22M56.86%30.68M39.33%27.69M68.24%90.91M66.65%27.68M71.20%23.79M57.71%19.56M78.68%19.88M67.86%54.03M82.79%16.61M
Operating profit -37.28%-40.43M-50.39%-38.11M-35.20%-34.75M-59.59%-114.36M-53.37%-33.86M-61.27%-29.45M-53.65%-25.34M-73.37%-25.7M-65.82%-71.66M-72.20%-22.08M
Net non-operating interest income expense 68.57%6.3M70.80%6.61M117.31%6.23M253.26%14.19M39.60%3.72M389.40%3.74M812.74%3.87M1,626.51%2.87M899.50%4.02M2,014.29%2.66M
Non-operating interest income 68.57%6.3M70.80%6.61M117.31%6.23M253.26%14.19M39.60%3.72M389.40%3.74M812.74%3.87M1,626.51%2.87M899.50%4.02M2,014.29%2.66M
Other net income (expense)
Income before tax -32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M
Income tax
Net income -32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M
Net income continuous Operations -32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M
Minority interest income
Net income attributable to the parent company -32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -32.73%-34.13M-46.71%-31.5M-24.90%-28.53M-48.08%-100.16M-55.26%-30.14M-46.95%-25.71M-33.62%-21.47M-55.78%-22.84M-57.99%-67.64M-52.92%-19.42M
Basic earnings per share 12.20%-0.360.94%-0.33688.33%-0.33-24.60%-1.57-56.67%-0.47-20.59%-0.41-6.25%-0.34-20.00%-0.36-10.53%-1.26-25.00%-0.3
Diluted earnings per share 12.20%-0.360.94%-0.33688.33%-0.33-24.60%-1.57-56.67%-0.47-20.59%-0.41-6.25%-0.34-20.00%-0.36-10.53%-1.26-25.00%-0.3
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data